Star Therapeutics Receives FDA Fast Track Designation for VGA039 in Von Willebrand Disease (VWD) By Kelly Mitten | January 6, 2025 | Comments Off on Star Therapeutics Receives FDA Fast Track Designation for VGA039 in Von Willebrand Disease (VWD) Read More
Star Therapeutics raises $90m in funding to advance antibody therapies By Blackwells Capital | September 5, 2023 | Comments Off on Star Therapeutics raises $90m in funding to advance antibody therapies Read More
Star Therapeutics adds another $90M to grow its galaxy of drug startups By Blackwells Capital | September 5, 2023 | Comments Off on Star Therapeutics adds another $90M to grow its galaxy of drug startups Read More
Investors shower Star Therapeutics with $90M for constellation of biotechs, antibody therapies By Blackwells Capital | September 5, 2023 | Comments Off on Investors shower Star Therapeutics with $90M for constellation of biotechs, antibody therapies Read More
